Stubborn Belly Fat? Explore Non-Invasive options in Our Clinical Study
Are you finding it challenging to shed those last bit of belly fat? Despite maintaining a healthy diet and regular exercise, our bodies can sometimes resist letting go of that weight due to various factors.
Wish there were more options for stubborn belly fat?
This clinical trial for an investigational belly fat loss treatment could help.
See if You Qualify
Fill out the form below to see if you meet the basic study requirements.
Who are we looking for?
To qualify for participation in the Abdominal Fat Reduction Study, individuals should have a body weight within the range of average to slightly overweight and maintain good overall health & a stable lifestyle, with belly fat that does not fold when standing. As part of this study, participants will be required to undergo MRI scans and receive up to four sets of injections, administered once every three weeks, at one of our designated research sites. Additionally, individuals must commit to attending scheduled screening and checkup appointments.
What is the purpose of this study?
Traditional methods of reducing abdominal fat through cosmetic procedures frequently involve surgical or invasive interventions. At Caliway Biopharmaceuticals, researchers are testing a potential alternative – a non-invasive option consisting of a series of injections.
Early investigations into these investigational injections have displayed encouraging outcomes, both in terms of reducing abdominal fat and ensuring safety. This study represents a continuation of that research.
Frequently asked questions
This investigational treatment may help to assist individuals dealing with surplus abdominal fat, offering them a pathway to attain their desired body composition without resorting to the extreme measures associated with invasive surgery.
To evaluate the efficacy of the investigational injections in reducing abdominal fat when compared to a placebo.
We have study locations available in the following cities: (city list)
25% of the people enrolled in the study will receive the placebo.
From start to finish, the study participation is about 21 weeks. The screening period is about 4 weeks. You could receive up to 4 treatments (3 weeks apart each). The treatment period is roughly 2 and a half months, or 10 weeks. Then the follow-up period is about 2 months, or 8 weeks.
Compensation is available for time and participation, but exact amounts vary by participating study site. Please ask your local study site for more details.
Your participation is entirely voluntary and can be ended at any time.